evitria AG

📍 Zürich-Fahrweid, Switzerland🗓 Founded 2010👥 29 employees💰 Last funded Jan 2019
Biotechnology Research🌐 evitria.com
Website LinkedIn
​evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies). With a track record of more than 120,000 successful antibody production runs for our clients, we can offer fast and reliable project execution at high quality standards (all production facilities in Switzerland) and affordable prices. Transfections are made with serum-free, animal-component free reagents. You can benefit from our expertise and unique focus when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in evitria AG?
evitria AG has 1 investors on record on gritt.io and 1 late-stage investors.
When did evitria AG last raise funding?
The most recent investment in evitria AG recorded on gritt.io was in January 2019.
When was evitria AG founded?
evitria AG was founded in 2010.
What industry is evitria AG in?
evitria AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is evitria AG based?
evitria AG is headquartered in Zürich-Fahrweid, Switzerland.